Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9146.122
uM
inf
inf
0.9694 0.9694 0.0000 -0.0404
-1.9847
1.3408
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
AU565
HER2amp
Luminal
CGC-11047
Polyamine analogue
9035.018
uM
536.59930
1000.00000
0.1872 -0.0935 0.2755 0.2729
0.8107
2.1555
AU565
HER2amp
Luminal
CGC-11047
Polyamine analogue
7793.018
uM
245.40250
372.22010
-0.9147 -0.9315 2.5250 0.5517
0.9016
1.3186
AU565
HER2amp
Luminal
CGC-11047
Polyamine analogue
9146.122
uM
inf
0.50973
0.5528 0.5712 1.2270 0.1353
0.9205
1.3408
AU565
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9035.017
uM
2.2380
6.31910
-0.9109 -0.9976 1.0569 0.5825
0.9942
2.2905
AU565
HER2amp
Luminal
CPT-11
TOP1
TOP
7793.007
uM
0.97073
1.86150
-0.6733 -0.6755 1.3129 0.4892
0.9947
1.3832
AU565
HER2amp
Luminal
CPT-11
TOP1
TOP
9146.121
uM
1.40740
2.19440
-0.6284 -0.6026 1.7804 0.4336
0.9975
1.1366
AU565
HER2amp
Luminal
Dactolisib
PI3K
PI3K
10880.155
uM
0.27813
0.23011
0.5266 0.3062 5.0000 0.3052
0.6953
1.5205
AU565
HER2amp
Luminal
Docetaxel
TUBB
TUBB
13030.002
uM
0.00092
0.00128
-0.9104 -0.8772 3.0709 1.3116
0.9975
0.5732
AU565
HER2amp
Luminal
Docetaxel
TUBB
TUBB
9146.002
uM
0.00498
0.00636
-0.6733 -0.6767 3.4844 0.9399
0.9984
1.2611
AU565
HER2amp
Luminal
Doxorubicin
TOP2
TOP
9146.121
uM
0.10032
0.22291
-0.9894 -0.9912 1.3687 0.9716
0.9813
1.1366
AU565
HER2amp
Luminal
Doxorubicin
TOP2
TOP
7793.007
uM
0.09387
0.22089
-0.9529 -0.9559 1.2490 0.9331
0.9887
1.3832
AU565
HER2amp
Luminal
Erlotinib
EGFR
ErbB
5900.092
uM
22.11190
37.99340
0.1765 -0.8772 1.8718 0.0574
0.9942
2.6334
AU565
HER2amp
Luminal
Erlotinib
EGFR
ErbB
5901.091
uM
8.69220
14.69410
-0.3289 -0.5059 1.3314 0.1854
0.9974
1.9229
AU565
HER2amp
Luminal
Etoposide
TOP2
TOP
5901.074
uM
0.51180
1.05610
-0.7095 -0.6601 1.1618 0.7400
0.9963
1.8718
AU565
HER2amp
Luminal
Everolimus
MTOR
MTOR
10880.156
uM
0.57383
7.51240
-0.8788 -1.0000 0.4272 0.4508
0.8269
1.5288
AU565
HER2amp
Luminal
FR180204
ERK1/2
MAPK
10880.149
uM
inf
inf
0.8678 0.8678 0.0000 0.0766
0.1343
1.6289
AU565
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
10880.154
uM
inf
inf
0.9251 0.9251 0.0000 0.0449
-0.1660
1.7853
AU565
HER2amp
Luminal
Gefitinib
EGFR
ErbB
7793.016
uM
0.65307
1.61880
-0.6853 -0.7468 1.0066 0.4341
0.9920
1.1616
AU565
HER2amp
Luminal
Gefitinib
EGFR
ErbB
7794.016
uM
2.89250
6.50790
-0.1897 -0.4920 0.8449 0.2166
0.9973
1.9541
21MT-1
HER2amp
-
Bortezomib
Proteasome
Proteasome
14779.203
uM
2.22370
3.73670
-0.7373 -0.7957 1.8347 0.4364
0.9894
1.9695
21MT-1
HER2amp
-
Bortezomib
Proteasome
Proteasome
14779.203
uM
2.22370
3.73670
-0.7373 -0.7957 1.8347 0.4364
0.9894
1.9695
BT-474
HER2amp
Luminal
CPT-11
TOP1
TOP
7798.077
uM
inf
inf
0.8883 0.8883 0.0000 -0.0257
0.4190
1.4371
BT-474
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9163.03
uM
26.3970
32.88280
-0.9993 -0.9998 5.0000 0.3249
0.9959
0.3535